The Albus is a program whose aim is to foster the creation of a scientific network and to increase the knowledge in the use of albumin as a therapeutic product. By supporting this program Grifols demonstrates its commitment to innovation in this field. We consider the program to be a tangible contribution to the improvement of standards and benefits for the patient care.

Application process for the ALBUS Awards 2025 closed.

The awardees will be announced in September 2025.

Applications for the next edition 2026 will be accepted between 01/11/2025 and 31/05/2026.

To see the 2024 ALBUS Award winner please click here.